An in-depth look to INFANT BACTERIAL THERAPEUTICS AB SER. B operating, investing, and financing activities

IBT_B free cash flow for Q2 24 is -37.97 M SEK. For 2023, IBT_B free cash flow was -101.22 M SEK and operating cash flow was -101.22 M SEK.